Integrated Diagnostics Holdings plc (IDGXF)

Market Cap	274.10M -15.8%
Revenue (ttm)	186.62M +35.5%
Net Income	31.19M +39.5%
EPS	0.05 +40.2%
Shares Out	n/a
PE Ratio	8.65
Forward PE	7.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.4700
Previous Close	0.5870
Day's Range	0.4700 - 0.4700
52-Week Range	0.4700 - 0.6983
Beta	0.42
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About IDGXF

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroe...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 7,137
• Stock Exchange: OTCMKTS
• Ticker Symbol: IDGXF

Financial Performance

In 2025, IDGXF's revenue was 7.86 billion, an increase of 37.34% compared to the previous year's 5.72 billion. Earnings were 1.26 billion, an increase of 17.15%.

Financial numbers in EGP

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error